These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 25149664)

  • 1. Dissection of mechanisms that account for imidazoline-induced lowering of blood glucose in mice.
    Stadlbauer K; Lehner Z; Stamenkovic N; Rustenbeck I; Surman L; Luger A; Fürnsinn C
    Eur J Pharmacol; 2014 Oct; 741():178-85. PubMed ID: 25149664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous characteristics of imidazoline-induced insulin secretion.
    Rustenbeck I; Leupolt L; Kowalewski R; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):235-42. PubMed ID: 10208311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.
    Shepherd RM; Hashmi MN; Kane C; Squires PE; Dunne MJ
    Br J Pharmacol; 1996 Nov; 119(5):911-6. PubMed ID: 8922740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazolines and the pancreatic B-cell. Actions and binding sites.
    Rustenbeck I; Köpp M; Ratzka P; Leupolt L; Hasselblatt A
    Ann N Y Acad Sci; 1999 Jun; 881():229-40. PubMed ID: 10415921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?
    Lehner Z; Stadlbauer K; Adorjan I; Rustenbeck I; Belz M; Fenzl A; de Cillia VA; Gruber D; Bauer L; Frobel K; Brunmair B; Luger A; Fürnsinn C
    Diabetologia; 2012 Nov; 55(11):3071-82. PubMed ID: 22898767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.
    Fagerholm V; Scheinin M; Haaparanta M
    Br J Pharmacol; 2008 Jul; 154(6):1287-96. PubMed ID: 18493247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of the insulinotropic action of first generation imidazolines by openers of K(ATP) channels.
    Wienbergen A; Bleck C; Lackmann TG; Rustenbeck I
    Biochem Pharmacol; 2007 Jan; 73(1):94-102. PubMed ID: 17056015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compounds.
    Bleck C; Wienbergen A; Rustenbeck I
    Diabetes; 2004 Dec; 53 Suppl 3():S135-9. PubMed ID: 15561901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.
    Jonas JC; Plant TD; Henquin JC
    Br J Pharmacol; 1992 Sep; 107(1):8-14. PubMed ID: 1358388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. I. Secretory and morphological studies.
    Rustenbeck I; Winkler M; Jörns A
    Biochem Pharmacol; 2001 Dec; 62(12):1685-94. PubMed ID: 11755122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
    Bleck C; Wienbergen A; Rustenbeck I
    Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro mechanism of action on insulin release of S-22068, a new putative antidiabetic compound.
    Le Brigand L; Virsolvy A; Manechez D; Godfroid JJ; Guardiola-Lemaître B; Gribble FM; Ashcroft FM; Bataille D
    Br J Pharmacol; 1999 Nov; 128(5):1021-6. PubMed ID: 10556939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of imidazoline binding site ligands on the growth and viability of clonal pancreatic beta-cells.
    Mourtada M; Elliott J; Smith SA; Morgan NG
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):146-54. PubMed ID: 10685869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cell toxicity of ATP-sensitive K+ channel-blocking insulin secretagogues.
    Rustenbeck I; Krautheim A; Jörns A; Steinfelder HJ
    Biochem Pharmacol; 2004 May; 67(9):1733-41. PubMed ID: 15081872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysaccharide isolated from Triticum aestivum stimulates insulin release from pancreatic cells via the ATP-sensitive K+ channel.
    Lee SH; Lim SW; Lee YM; Lee HS; Kim DK
    Int J Mol Med; 2012 May; 29(5):913-9. PubMed ID: 22322245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors.
    Schulz A; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):321-7. PubMed ID: 2572976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of imidazoline compounds on cytoplasmic Ca2+ concentration and ATP-sensitive K+ channels in pancreatic B-cells.
    Rustenbeck I; Kowalewski R; Herrmann C; Dickel C; Ratzka P; Hasselblatt A
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():42-5. PubMed ID: 8839253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets.
    Yokota S; Hikasa Y; Shimura I; Kusunose S
    Am J Vet Res; 2013 Mar; 74(3):395-402. PubMed ID: 23438114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.